Prudential Financial
PHAT icon

Prudential Financial’s Phathom Pharmaceuticals PHAT Stock Holding History

Prudential Financial’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-568,630
Closed -$3.57M – 2492
2025
Q1 		$3.57M Buy
568,630
+105,290
+23% +$639K 0.01% 1007
2024
Q4 		$3.76M Buy
463,340
+48,000
+12% +$594K 0.01% 989
2024
Q3 		$7.51M Buy
415,340
+63,000
+18% +$881K 0.01% 801
2024
Q2 		$3.63M Buy
+352,340
New +$3.63M 0.01% 1067

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Prudential Financial's PHAT Position: Q2 2025 in Review

Prudential Financial sold out of Phathom Pharmaceuticals (PHAT) in Q2 2025, closing a stake of 568,630 shares — an estimated $3.57M sold.

Prudential Financial first reported a position in PHAT in Q2 2024 and held it in 4 quarters. The position peaked at $7.51M in Q3 2024. 117 funds tracked by Wall St. Rank hold PHAT as of Q2 2025.

  • Prudential Financial reported no remaining Phathom Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 568,630 Phathom Pharmaceuticals shares in Q2 2025, an estimated $3.57M.
  • Prudential Financial first reported a position in Phathom Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Prudential Financial's Phathom Pharmaceuticals position peaked at $7.51M in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.